MetaCap

Palisade Bio (PALI) News

NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.54+0.09 (+6.21%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

PALI news summary

We found 1 recent headline mentioning Palisade Bio (PALI): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. PALI is making an outsized move today, up 6.21% at $1.54, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Raymond James Initiates Coverage of Palisade Bio with Outperform", was published by Nasdaq on Oct 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Palisade Bio headlines

Compare PALI